A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS
Clinical trial NCT05279755 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05279755
- Sponsor
- ProJenX
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-26
- Primary completion
- 2026-06-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.